Education
About Us
Working with TipRanks
Follow Us
Toray Industries (TRYIY)
:TRYIY
Paclitaxel, Ramucirumab, Trk-950
Gastric Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase II
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Aug 29, 2023
―
Nivolumab, Trk-950
Melanoma, Solid Tumor
Phase I/II
Active Not Recruiting
A Study of TRK-950 in Patients With Advanced Solid Tumors
Jun 14, 2022
―
Gemcitabine, Pembrolizumab, Bevacizumab, Nivolumab, Irinotecan, Paclitaxel, Carboplatin, Cisplatin, Leucovorin, Ramucirumab, Pld, Trk-950, 5-Fu, Imiquimod Cream
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Renal Cell Carcinoma, Solid Tumor, Gastric Cancer, Cholangiocarcinoma, Primary Peritoneal Cancer, Palpable Subcutaneous Malignant Lesions
Phase I
Active Not Recruiting
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
Mar 07, 2019
―
Trk-950
Colon Cancer, Cholangiocarcinoma, Locally Advanced Or Metastatic Solid Carcinomas
Phase I
Completed
A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors
Nov 29, 2016
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Toray Industries (TRYIY) have in its pipeline
TRYIY is currently developing the following drugs: Paclitaxel, Ramucirumab, Trk-950, Nivolumab, Trk-950, Gemcitabine, Pembrolizumab, Bevacizumab, Nivolumab, Irinotecan, Paclitaxel, Carboplatin, Cisplatin, Leucovorin, Ramucirumab, Pld, Trk-950, 5-Fu, Imiquimod Cream. These drug candidates are in various stages of clinical development as the company works toward FDA approval.